Fluorescence in situ hybridization analysis of masked (8;21)(q22;q22) translocations

Cancer Genetics and Cytogenetics

Volumn 112, Issue 1, 1999, Pages 15-20

  Harrison, Christine J ^a   Radford Weiss, Isabelle ^a   Ross, Fiona ^b   Rack, Katrina ^a   Le Guyader, Gaelle ^a   Vekemans, Michel ^a   Macintyre, Elizabeth ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b WESSEX REGIONAL GENETICS LABORATORY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE MYELOBLASTIC LEUKEMIA; ADULT; ARTICLE; CASE REPORT; CHILD; CHROMOSOME ANALYSIS; CHROMOSOME REARRANGEMENT; CHROMOSOME TRANSLOCATION; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; KARYOTYPE; MALE; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0033167060     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(98)00244-1     Document Type: Article

References (25)

1. Bennett J.M., Catovsky D., Daniel M.T., Flandrin G., Galton D.A., Gralnick H.R., Sultan C. Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group. Br J Haematol. 33:1976;451-458.
2. Bennett J.M., Catovsky D., Daniel M., Flandrin G., Galton D.A.G., Gralnick H.R., Sultan C. Proposed revised criteria for the classification of acute myeloid leukemia. Ann Intern Med. 103:1985;626-629.
3. Heim S., Mitelman F. Cancer Cytogenetics. 1995;Wiley-Liss, New York.
4. Heim S., Mitelman F. Cytogenetic analysis in the diagnosis of acute leukemia. Cancer Supp. 70:1992;1701-1709.
5. Grimwade D., Walker H., Oliver F., Wheatley K., Harrison C.J., Harrison G., Rees J., Hann I., Stevens R., Burnett A., Goldstone A. The importance of diagnostic cytogenetics on outcome in AML. analysis of 1,612 patients entered into the MRC AML 10 trial Blood. 92:1998;2322-2333.
6. Miyoshi H., Shimizu K., Kozu T., Maseki N., Kaneko Y., Ohki M. t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region on a single gene, AML1. Proc Natl Acad Sci USA. 88:1991;10431-10434.
7. Wang S., Speck N.A. Purification of core-binding factor, a protein that binds the conserved core site in murine leukemia virus enhancers. Mol Cell Biol. 12:1992;89-102.
8. Wang S., Wang Q., Crute B.E., Melnikova I.N., Keller S.R., Speck N.A. Cloning and characterization of sub-units of the T-cell receptor and murine leukemia virus enhancer core-binding factor. Mol Cell Biol. 13:1993;3324-3339.
9. Erickson P., Gao J., Chang K., Look T., Whisenant E., Raimondi S., Lasher R., Trujillo J., Rowley J.D., Drabkin H.A. Identification of breakpoints in t(8;21) acute myelogenous leukemia and isolation of a fusion transcript, AML1/ETO, with similarity to Drosophila segmentation gene, RUNT. Blood. 80:1992;1825-1831.
10. Nisson P.E., Watkins P.C., Sacchi N. Transcriptionally active chimeric gene derived from the fusion of the AML1 gene and a novel gene on chromosome 8 in t(8;21) leukemic cells. Cancer Genet Cytogenet. 63:1992;81-88.
11. Miyoshi H., Kozu T., Shimizu K., Enomoto K., Maseki N., Kaneko Y., Kamada N., Ohki M. The t(8;21) translocation in acute myeloid leukemia results in production of an AML1-MTG8 fusion transcript. Embo J. 12:1993;2715-2721.
12. Andrieu V., Radford-Weiss I., Troussard X., Chane C., Valensi F., Guesnu M., Haddad E., Viguier F., Dreyfus F., Varet B., Flandrin G., MacIntyre E. Molecular detection of t(8;21)/AML1-ETO in AML M1/M2. correlation with cytogenetics, morphology and immunophentype Br J Haematol. 92:1996;855-865.
13. Tighe J.E., Daga A., Calabi F. Translocation breakpoints are clustered on both chromosome 8 and chromosome 21 in the t(8;21) of acute myeloid leukemia. Blood. 81:1993;592-596.
14. Shimizu K., Miyoshi H., Kozu T., Nagata J., Enomoto K., Maseki N., Kaneko Y., Okhi M. Consistent disruption of the AML1 gene occurs within a single intron in the t(8;21) chromosomal translocation. Cancer Res. 52:1992;6945-6948.
15. Sacchi N., Magnani I., Kearney L., Wijsman J., Hagemeijer A., Darfler M. Interphase cytogenetics of the t(8;21)(q22;q22) associated with acute myelogenous leukemia by two-color fluorescence in situ hybridization. Cancer Genet Cytogenet. 79:1995;97-103.
16. Hagemeijer A., de Klein A., Wijsman J., van Meerten E., de Greef G.E., Sacchi N. Development of an interphase fluorescent in situ hybridization (FISH) test to detect t(8;21) in AML patients. Leukemia. 12:1998;96-101.
17. Groupe Francaise de Cytogenetique Hematologique Acute myelogenous leukemia with an 8:21 translocation. A report of 148 cases from the Groupe Francaise de Cytogenetique Hematologique. Cancer Genet Cytogenet. 44:1990;169-179.
18. Saitoh K., Miura I., Ohshima A., Takahashi N., Kume M., Utsumi S., Kobayashi Y., Hashimoto K., Hatano Y., Nimura T., Saito M., Enomoto K., Ohhira M., Shimizu K., Ohki M., Miura A.B. Translocation (8;12;21)(q22.1;q24.1;q22.1). A new masked type of t(8;21)(q22;q22) in a patient with acute myeloid leukemia Cancer Genet Cytogenet. 96:1997;111-114.
19. Berger R., Le Coniat M., Romana S.P., Jonveaux P. Secondary acute myeloblastic leukemia with t(16;21)(q24;q22) involving the AML1 gene. Hematol Cell Ther. 38:1996;1-4.
20. Tai A.S., Ross F.M., Vickers M., Choudhury D.N., Harvey J.F., Barber J.C.K., Barton C., Smith A.G. t(8;21) myelodysplasia, an early presentation of M2 AML. Br J Haematol. 89:1995;890-892.
21. Lehrach H, Drmanac R, Hoheisel J, Larin Z, Lennon G, Monaco AP, Nizetic D, Zehetner G, Poustka A (1990): In: Genome Analysis, Volume 1: Genetic and Physical Mapping. David KE, Tilgham SM. eds. Cold Spring Harbor Laboratory Press 39-81.
22. Berger R., Bernheim A., Daniel M.T., Valensi F., Sigaux F., Flandrin G. Cytologic characterization and significance of normal karyotypes in t(8;21) acute myeloblastic leukemia. Blood. 59:1982;171-178.
23. Swirsky D.M., Li Y.S., Matthews J.G., Flemans R.J., Rees J.K., Hayhoe F.G. 8;21 translocation in acute granulocytic leukaemia. cytological, cytochemical and clinical features Br J Haematol. 56:1984;199-213.
24. Trujillo J.M., Cork A., Ahearn M.J., Youness E.L., McCredie K.B. Hematologic and cytologic characterization of 8/21 translocation acute granulocytic leukemia. Blood. 53:1979;695-706.
25. Nucifora G., Dickstein J.I., Torbenson V., Roulston D., Rowley J.D., Vardiman J.W. Correlation between cell morphology and expression of the AML1/ETO chimeric transcript in patients with acute myeloid leukemia without the t(8;21). Leukemia. 8:1994;1553-1575.